161 related articles for article (PubMed ID: 12709032)
1. A global view on prophylaxis: possibilities and consequences.
Shapiro AD
Haemophilia; 2003 May; 9 Suppl 1():10-7; discussion 18. PubMed ID: 12709032
[TBL] [Abstract][Full Text] [Related]
2. Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy.
Giampaolo A; Abbonizio F; Puopolo M; Arcieri R; Mannucci PM; ; Hassan HJ; Accorsi A; Ettorre PC; Schiavoni M; Palareti G; Rodorigo G; Valdré L; Amaddii G; Billio A; Notarangelo L; Iannacaro P; Muleo P; Biasioli C; Rossi V; Alatri A; Testa S; Vincenzi D; Scapoli G; Morfini M; Molinari AC; Lapecorella M; Mariani G; Baudo F; Caimi MT; Federici AB; Gringeri A; Mannucci PM; Santagostino E; Marietta M; Coppola A; Di Minno G; Perricone C; Schiavulli M; Miraglia E; Rocino A; Zanon E; Gagliano F; Mancuso G; Siragusa S; Rivolta F; Tagliaferri A; Gamba G; Iorio A; Oliovecchio E; Dragani A; Arbasi MC; Albertini P; Mancino A; Lombardo VT; Latella C; D'Incà M; Landolfi Raffaele ; Biondo Francesca ; Mazzucconi MG; Santoro Cristina ; Mameli AL; Piseddu G; Schinco PC; Messina M; Rossetti G; Barillari G; Feola G; Franchini M; Gandini G; Castaman G; Rodeghiero F
Transfus Med; 2011 Aug; 21(4):280-4. PubMed ID: 21733006
[No Abstract] [Full Text] [Related]
3. When should prophylactic treatment in patients with haemophilia A and B start?--The German experience.
Kreuz W; Escuriola-Ettingshausen C; Funk M; Schmidt H; Kornhuber B
Haemophilia; 1998 Jul; 4(4):413-7. PubMed ID: 9873763
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic therapy for hemophilia in a developing country, Turkey.
Kavakli K; Nişli G; Aydinok Y; Oztop S; Cetingül N; Aydoğdu S; Yalman O
Pediatr Hematol Oncol; 1997; 14(2):151-9. PubMed ID: 9089743
[TBL] [Abstract][Full Text] [Related]
5. Aspects of haemophilia prophylaxis in Sweden.
Ljung RC
Haemophilia; 2002 Mar; 8 Suppl 2():34-7. PubMed ID: 11966851
[TBL] [Abstract][Full Text] [Related]
6. The treatment of haemophilia, including prophylaxis, constant infusion and DDAVP.
Berntorp E
Baillieres Clin Haematol; 1996 Jun; 9(2):259-71. PubMed ID: 8800504
[TBL] [Abstract][Full Text] [Related]
7. A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment center.
Dodd C; Watts RG
Haemophilia; 2012 Jul; 18(4):561-7. PubMed ID: 22221939
[TBL] [Abstract][Full Text] [Related]
8. Is haemophilia prophylaxis achievable in the context of self-sufficiency?
Nilsson IM
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S71-5. PubMed ID: 7795143
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis for severe haemophilia: clinical and economical issues.
Fischer K; Van Den Berg M
Haemophilia; 2003 Jul; 9(4):376-81. PubMed ID: 12828671
[TBL] [Abstract][Full Text] [Related]
10. [Long-term low-dose secondary prophylaxis for severe and moderate hemophilia children with arthropathy in China: a single-center observation study].
Wu RH; Wu XY; Zhang NN; Zhao L; Zhang JS; Zhen YZ; Peng Y
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):632-4. PubMed ID: 23906463
[No Abstract] [Full Text] [Related]
11. Role of enhanced half-life factor VIII and IX in the treatment of haemophilia.
Mahdi AJ; Obaji SG; Collins PW
Br J Haematol; 2015 Jun; 169(6):768-76. PubMed ID: 25754016
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic factor replacement in hemophilia.
Carcao MD; Aledort L
Blood Rev; 2004 Jun; 18(2):101-13. PubMed ID: 15010149
[TBL] [Abstract][Full Text] [Related]
13. Results of secondary prophylaxis in children with severe hemophilia.
Manco-Johnson MJ; Nuss R; Geraghty S; Funk S; Kilcoyne R
Am J Hematol; 1994 Oct; 47(2):113-7. PubMed ID: 8092125
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis for hemophilia: state of the art or state of confusion?
Gruppo RA
J Pediatr; 1998 Jun; 132(6):915-7. PubMed ID: 9627577
[No Abstract] [Full Text] [Related]
15. Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspective.
Björkman S
Haemophilia; 2003 May; 9 Suppl 1():101-8; discussion 109-10. PubMed ID: 12709045
[TBL] [Abstract][Full Text] [Related]
16. Issues in pediatric haemophilia care.
Giordano P; Franchini M; Lassandro G; Faienza MF; Valente R; Molinari AC
Ital J Pediatr; 2013 Apr; 39():24. PubMed ID: 23601343
[TBL] [Abstract][Full Text] [Related]
17. Primary prophylaxis in haemophilia care: Guideline update 2016.
Fischer K; Ljung R
Blood Cells Mol Dis; 2017 Sep; 67():81-85. PubMed ID: 28302350
[TBL] [Abstract][Full Text] [Related]
18. Economics of prophylactic treatment.
Schramm W; Berger K
Haemophilia; 2003 May; 9 Suppl 1():111-5; dicussion 116. PubMed ID: 12709046
[TBL] [Abstract][Full Text] [Related]
19. Update on treatment regimens: prophylaxis versus on-demand therapy.
Manco-Johnson MJ
Semin Hematol; 2003 Jul; 40(3 Suppl 3):3-9. PubMed ID: 14690062
[TBL] [Abstract][Full Text] [Related]
20. Models of prophylaxis.
Berntorp E; Fischer K; Miners A
Haemophilia; 2012 Jul; 18 Suppl 4():136-40. PubMed ID: 22726097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
